#cellproliferation
October 6, 2025 at 5:23 PM
Are you looking for a biomarker to support your oncology drug development program?

TKa supports dose optimization, assisting pharma assess treatment effect, refine dosing strategies, and make decisions on candidate- and dose selection.

DiviTum®TKa is FDA 510(k) cleared and is available as RUO.
April 19, 2026 at 4:01 PM
This study shows that #HBOTherapy exerts #Antitumor effects in #Glioblastoma, promoting #Apoptosis, inhibiting #Inflammation, reducing #CellProliferation, suppressing #TumorGrowth & #Metastasis, regulating #Vascularization, & thus prolonging patient survival. #medsky

Read: doi.org/10.1007/s115...
March 16, 2026 at 12:15 PM
New article in JHC: "Loss of Macrophage Migration Inhibitory Factor (MIF) Alters the Timing of Ventral Prostate Maturation in Mice."

Click to read: journals.sagepub.com/doi/abs/10.1...

#androgen #cellproliferation #immunohistochemistry
July 14, 2026 at 8:58 PM
Not all proliferation assays measure the same thing.

Our guide compares five established approaches plus the new Lumit® Cell Proliferation Assay with a side-by-side comparison to help choose the right method.

Read the guide at: https://ow.ly/xebg50Zk2rK

#CellProliferation #Bioassays
July 14, 2026 at 8:05 AM
New article in JHC: "Loss of Macrophage Migration Inhibitory Factor (MIF) Alters the Timing of Ventral Prostate Maturation in Mice."

Click to read: journals.sagepub.com/doi/abs/10.1...

#androgen #cellproliferation #immunohistochemistry
June 29, 2026 at 8:59 PM
New article in JHC: "Loss of Macrophage Migration Inhibitory Factor (MIF) Alters the Timing of Ventral Prostate Maturation in Mice."

Click to read: journals.sagepub.com/doi/abs/10.1...

#androgen #cellproliferation #immunohistochemistry
June 15, 2026 at 10:39 PM
This study demonstrates that #Prox1 suppresses #Retinoblastoma (RB) #CellProliferation and #DrugResistance through regulation of #Notch1, positioning Prox1 as a promising therapeutic target in RB and opening new avenues for #TranslationalOncology. #medsky

Read: link.springer.com/article/10.1...
January 8, 2026 at 12:05 PM
This study reports that #GSPT1 plays a crucial role in #HepatocellularCarcinoma (HCC) by promoting #Cancer #CellProliferation and driving migration and invasion, highlighting it as a potential #diagnostic and #PrognosticMarker for HCC. #medsky

To read: link.springer.com/article/10.1...
November 26, 2025 at 9:00 AM
This study shows that #lncRNA PCED1B-AS1 is upregulated in #HepatocellularCarcinoma (HCC), promoting #Tumor #CellProliferation & invasion via the #miR-34a/CD44 axis, highlighting PCED1B-AS1 as a potential #therapeutic target for HCC. #medsky

Read: link.springer.com/article/10.1...
November 9, 2025 at 9:30 AM
This study shows that prospero homeobox 1 (#Prox1) reduces #CellProliferation and #DrugResistance in #Retinoblastoma (RB) by targeting Notch1, positioning Prox1 as a potential #therapeutic target for RB. #medsky

Read more:
Prox1 Suppresses Proliferation and Drug Resistance of Retinoblastoma Cells via Targeting Notch1 - Current Medical Science
Objective Retinoblastoma (RB) is a prevalent type of eye cancer in youngsters. Prospero homeobox 1 (Prox1) is a homeobox transcriptional repressor and downstream target of the proneural gene that is…
link.springer.com
October 8, 2025 at 12:52 PM
@delarueresearch.bsky.social from @laascnrs.bsky.social is studying the common physical or biological response that leads to a decrease in cell proliferation, work which holds wider relevance to our understanding of cancer.

issuu.com/euresearcher...

#Research #CancerResearch #CellProliferation
June 12, 2026 at 8:53 AM
New research article on #LiverRegeneration!

Activation of Piezo-1 in VECs leads to the up-regulation of HBEGF, EREG, & AREG genes in the ERBB signaling pathway via the PKCα-ERK1/2 axis, which activates EGFR in hepatocytes to promote #CellProliferation. #medsky

#OpenAccess: www.sciencedirect.co...
March 14, 2025 at 2:00 PM